Solifenacin (Vesicare)
Antimuscarinic (anticholinergic) urinary antispasmodic
Solifenacin (Vesicare)
Forms and strengths
Form: TabletStrength: 5 mg, 10 mg
References
Indication
- Solifenacin (Vesicare) is used to treat overactive bladder in adults, including symptoms of urgency, frequent urination, and urge urinary incontinence.
Pregnancy
- There is no adequate data on the use of solifenacin in pregnant women; it should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.
- Women of childbearing potential should use adequate contraception while being considered for treatment.
Breastfeeding
- It is not known whether solifenacin passes into human breast milk.
- Because many drugs do pass into breast milk, solifenacin should not be used while breastfeeding; a decision should be made to either stop breastfeeding or stop the medication.
Geriatrics
- Solifenacin has shown similar safety and effectiveness in older adults 65 years and older compared with younger patients in clinical studies.
- Blood levels of solifenacin are somewhat higher in older adults, so caution is warranted, particularly in those with reduced kidney or liver function.
Pediatrics
- Safety and effectiveness of solifenacin have not been established in children, so it is not indicated for pediatric use.
Dosage & Administration
- The recommended starting dose of Vesicare is 5 mg once daily.
- If the 5 mg dose is well tolerated, the dose may be increased to 10 mg once daily.
- The maximum effect on bladder symptoms can take up to 4 weeks to become apparent.
- For patients with severe kidney impairment, or moderate liver impairment, the dose should not exceed 5 mg daily; Vesicare is not recommended for patients with severe liver impairment.
- When used with a strong CYP3A4 inhibitor such as ketoconazole, the dose should be limited to 5 mg daily.
- Vesicare should be swallowed whole with liquid; it can be taken with or without food.
- If a dose is missed, the next tablet should be taken as scheduled; doses should not be doubled.
Overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- Overdose with solifenacin can cause severe anticholinergic effects, including fixed and dilated pupils, blurred vision, tremor, dry skin, and problems with balance and coordination.
- The highest known accidental overdose caused mental status changes that resolved after treatment with activated charcoal.
- Symptoms from repeated high daily doses have resolved within about a week after stopping the drug.
- Treatment of overdose includes gastric lavage, supportive care, and ECG (heart rhythm) monitoring.
Common side effects
- Dry mouth may occur, and is more common at the higher dose.
- Constipation may occur.
- Blurred vision may occur.
- Nausea may occur.
- Indigestion (dyspepsia) may occur.
- Upper abdominal pain may occur.
- Dry eyes may occur.
- Fatigue may occur.
- Swelling of the lower legs may occur.
- Urinary tract infection symptoms may occur.
Serious side effects
Serious side effects require immediate discussion with the prescriber or emergency care.
- Angioedema, meaning swelling of the face, lips, tongue, or throat, has been reported, sometimes after the very first dose, and can be life-threatening if it affects the airway.
- Anaphylactic (severe allergic) reactions have been reported.
- Severe constipation, including fecal impaction or bowel obstruction, has occurred rarely, especially at the 10 mg dose.
- Urinary retention, meaning inability to empty the bladder, may occur, particularly in patients with bladder outflow obstruction.
- QT interval prolongation and Torsade de Pointes, a dangerous heart rhythm, have been reported, particularly at higher doses or in patients with existing risk factors.
- Severe skin reactions, including exfoliative dermatitis and erythema multiforme, have been reported.
- Reduced ability to sweat can lead to heat prostration in hot conditions or with strenuous activity.
- Confusion, disorientation, delirium, and hallucinations have been reported, particularly in older adults.
- Liver function test abnormalities have been reported.
- Seek urgent medical attention for swelling of the face, lips, tongue, or throat, difficulty breathing, severe abdominal pain, or an inability to urinate.
Use with caution
- Use with caution in patients with reduced ability to sweat, due to the risk of overheating in hot weather or during exercise.
- Use with caution in patients with bladder outflow obstruction, due to the risk of urinary retention.
- Use with caution in patients with reduced gastrointestinal motility.
- Use with caution in patients with reduced liver or kidney function, with dose limits as described above.
- Use with caution in patients with a history of QT prolongation, electrolyte disturbances, or who take other medications that can affect heart rhythm.
- Use with caution in patients with pre-existing heart disease.
- Use with caution when driving or operating machinery, since blurred vision and drowsiness can occur.
Contraindications
- Contraindicated in patients with urinary retention.
- Contraindicated in patients who are dependent on dialysis.
- Contraindicated in patients with gastroparesis (delayed stomach emptying).
- Contraindicated in patients with uncontrolled narrow-angle glaucoma.
- Contraindicated in patients with known hypersensitivity to solifenacin or any ingredient in the formulation.
Drug interactions
- Other medications with anticholinergic effects can add to solifenacin's effects and side effects, such as dry mouth, constipation, and blurred vision.
- Cholinergic drugs may have reduced effect when combined with solifenacin, since solifenacin works against this system.
- Solifenacin may reduce the effectiveness of drugs that stimulate gut motility, such as metoclopramide.
- Strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, and erythromycin, can significantly raise solifenacin blood levels, requiring a dose limit of 5 mg daily.
- No significant interaction has been found between solifenacin and digoxin, oral contraceptives, or warfarin.
Food interactions
- Vesicare can be taken with or without food; there is no significant effect of food on how the medicine is absorbed.
- Grapefruit juice may increase solifenacin blood levels and should be used with caution.
Time of administration
- Vesicare is taken once daily, at about the same time each day, and can be taken with or without food.
- It may take up to 4 weeks of regular use to see the full benefit for bladder symptoms.
Storage
- Store Vesicare tablets between 15°C and 30°C.
Patient take-away
- Vesicare (solifenacin) is taken once daily to help reduce bladder urgency, frequency, and leakage from an overactive bladder.
- Dry mouth and constipation are the most common side effects; staying hydrated and eating enough fibre can help.
- Because this medicine can reduce sweating, take care to avoid overheating in hot weather or during exercise.
- Seek urgent medical care for swelling of the face or throat, difficulty breathing, or an inability to urinate.
- It can take up to 4 weeks of regular use to notice the full benefit.